Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 3;95(2):348-53.
doi: 10.4269/ajtmh.16-0059. Epub 2016 Jun 6.

Prevalence of Hepatitis B Virus Infection in Kenya, 2007

Kathleen N Ly  1 , Andrea A Kim  2 , Mamo Umuro  3 , Jan Drobenuic  4 , John M Williamson  5 , Joel M Montgomery  6 , Barry S Fields  6 , Eyasu H Teshale  4
Affiliations

Prevalence of Hepatitis B Virus Infection in Kenya, 2007

Kathleen N Ly et al. Am J Trop Med Hyg. .

Abstract

Current estimates put the prevalence of hepatitis B virus (HBV) infection in Kenya at 5-8%. We determined the HBV infection prevalence in the human immunodeficiency virus (HIV)-negative Kenyan adult and adolescent population based on samples collected from a national survey. We analyzed data from HIV-negative participants in the 2007 Kenya AIDS Indicator Survey to estimate the HBV infection prevalence. We defined past or present HBV infection as presence of total hepatitis B core antibody (HBcAb), and chronic HBV infection (CHBI) as presence of both total HBcAb and hepatitis B surface antigen (HBsAg). We calculated crude and adjusted odds of HBV infection by demographic characteristics and risk factors using logistic regression analyses. Of 1,091 participants aged 15-64 years, approximately 31.5% (95% confidence interval [CI] = 28.0-35.3%) had exposure to HBV, corresponding to approximately 6.1 million (CI = 5.4-6.8 million) with past or present HBV infection. The estimated prevalence of CHBI was 2.1% (95% CI = 1.4-3.1%), corresponding to approximately 398,000 (CI = 261,000-602,000) with CHBI. CHBI is a major public health problem in Kenya, affecting approximately 400,000 persons. Knowing the HBV infection prevalence at baseline is important for planning and public health policy decision making and for monitoring the impact of viral hepatitis prevention programs.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Sampling diagram of participants selected for hepatitis B testing in the Kenya AIDS Indicator Survey, 2007.
See this image and copyright information in PMC

References

    1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–2219. - PubMed
    1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–1555. - PubMed
    1. Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci. 2009;9:98–108. - PMC - PubMed
    1. Hyams KC, Morrill JC, Woody JN, Okoth FA, Tukei PM, Mugambi M, Johnson B, Gray GC. Epidemiology of hepatitis B in eastern Kenya. J Med Virol. 1989;28:106–109. - PubMed
    1. Mutuma GZ, Mbuchi MW, Zeyhle E, Fasana R, Okoth FA, Kabanga JM, Julius K, Shiramba TL, Njenga MK, Kaiguri PM, Osidiana V. Prevalence of hepatitis B virus (HBV) surface antigen and HBV-associated hepatocellular carcinoma in Kenyans of various ages. Afr J Health Sci. 2011;18:53–61.

Publication types

MeSH terms

Substances

LinkOut - more resources